NM_000512.5:c.850T>G

Variant summary

Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PS3PM1PM5PP5

The NM_000512.5(GALNS):​c.850T>G​(p.Phe284Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000333 in 1,610,180 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV000399640: Enzyme activity in the individual who was compound hetereozygous for the variant was demonstrated to be only 4% of wild type (Morrone et al. 2014).". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F284C) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00035 ( 0 hom. )

Consequence

GALNS
NM_000512.5 missense

Scores

5
6
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:8U:2

Conservation

PhyloP100: 9.09

Publications

11 publications found
Variant links:
Genes affected
GALNS (HGNC:4122): (galactosamine (N-acetyl)-6-sulfatase) This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq, Jul 2008]
GALNS Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 4A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 9 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000399640: Enzyme activity in the individual who was compound hetereozygous for the variant was demonstrated to be only 4% of wild type (Morrone et al. 2014).
PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 13 uncertain in NM_000512.5
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-88835260-A-C is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 2840507.Status of the report is criteria_provided_single_submitter, 1 stars.
PP5
Variant 16-88835261-A-C is Pathogenic according to our data. Variant chr16-88835261-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 321200.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000512.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNS
NM_000512.5
MANE Select
c.850T>Gp.Phe284Val
missense
Exon 8 of 14NP_000503.1P34059
GALNS
NM_001323544.2
c.868T>Gp.Phe290Val
missense
Exon 9 of 15NP_001310473.1
GALNS
NM_001323543.2
c.295T>Gp.Phe99Val
missense
Exon 7 of 13NP_001310472.1Q6YL38

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNS
ENST00000268695.10
TSL:1 MANE Select
c.850T>Gp.Phe284Val
missense
Exon 8 of 14ENSP00000268695.5P34059
GALNS
ENST00000562593.5
TSL:1
n.4259T>G
non_coding_transcript_exon
Exon 6 of 12
GALNS
ENST00000862787.1
c.961T>Gp.Phe321Val
missense
Exon 9 of 15ENSP00000532846.1

Frequencies

GnomAD3 genomes
AF:
0.000210
AC:
32
AN:
152176
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000830
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000220
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000217
AC:
53
AN:
244338
AF XY:
0.000272
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000118
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000275
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000380
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000346
AC:
504
AN:
1457886
Hom.:
0
Cov.:
32
AF XY:
0.000326
AC XY:
236
AN XY:
724812
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33430
American (AMR)
AF:
0.0000904
AC:
4
AN:
44248
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25930
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39648
South Asian (SAS)
AF:
0.000352
AC:
30
AN:
85296
European-Finnish (FIN)
AF:
0.0000188
AC:
1
AN:
53134
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.000395
AC:
439
AN:
1110194
Other (OTH)
AF:
0.000332
AC:
20
AN:
60244
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000210
AC:
32
AN:
152294
Hom.:
1
Cov.:
32
AF XY:
0.000161
AC XY:
12
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41554
American (AMR)
AF:
0.000392
AC:
6
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.000831
AC:
4
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
68020
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000370
Hom.:
0
Bravo
AF:
0.000223
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000231
AC:
28

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
5
1
-
Mucopolysaccharidosis, MPS-IV-A (6)
2
-
-
Morquio syndrome (2)
1
1
-
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Pathogenic
0.17
D
BayesDel_noAF
Pathogenic
0.33
CADD
Benign
19
DANN
Benign
0.46
DEOGEN2
Uncertain
0.70
D
Eigen
Benign
-0.10
Eigen_PC
Benign
0.017
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D
M_CAP
Pathogenic
0.29
D
MetaRNN
Uncertain
0.69
D
MetaSVM
Uncertain
0.021
D
MutationAssessor
Benign
-1.2
N
PhyloP100
9.1
PrimateAI
Uncertain
0.67
T
PROVEAN
Uncertain
-2.4
N
REVEL
Pathogenic
0.74
Sift
Benign
0.91
T
Sift4G
Benign
0.58
T
Polyphen
0.30
B
Vest4
0.93
MVP
0.99
MPC
0.19
ClinPred
0.99
D
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.83
gMVP
0.88
Mutation Taster
=4/96
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144067930; hg19: chr16-88901669; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.